CUPRIC SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cupric Sulfate, and when can generic versions of Cupric Sulfate launch?
Cupric Sulfate is a drug marketed by Abraxis Pharm and Am Regent and is included in two NDAs.
The generic ingredient in CUPRIC SULFATE is cupric sulfate. Additional details are available on the cupric sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cupric Sulfate
A generic version of CUPRIC SULFATE was approved as cupric sulfate by AM REGENT on December 16th, 2022.
Summary for CUPRIC SULFATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Patent Applications: | 13 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CUPRIC SULFATE at DailyMed |
US Patents and Regulatory Information for CUPRIC SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 019350-001 | May 5, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Am Regent | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 216324-001 | Dec 16, 2022 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
